Amy Elizabeth Gonzalez, M.D. Preventive Medicine - Occupational Medicine Medicare: Accepting Medicare Assignments Practice Location: 1905 Beaver Ruin Rd, Norcross, GA 30071 Phone: 615-778-4066 Fax: 615-778-9114 |
Dr. Louise Farmer Sheffield, MD Preventive Medicine - Occupational Medicine Medicare: Not Enrolled in Medicare Practice Location: 6825 Jimmy Carter Blvd, Suite1100, Norcross, GA 30071 Phone: 404-855-3300 Fax: 404-855-4331 |
Jane Turley Stclair, MD,MPH Preventive Medicine - Occupational Medicine Medicare: Not Enrolled in Medicare Practice Location: 6825 Jimmy Carter Blvd, Suite 1100, Norcross, GA 30071 Phone: 770-449-5161 Fax: 770-449-3272 |
Jennifer L Andreae, THERAPY DIR. I Preventive Medicine - Preventive Medicine/Occupational Environmental Medicine Medicare: Not Enrolled in Medicare Practice Location: 1905 Beaver Ruin Rd, Norcross, GA 30071 Phone: 615-778-4066 |
Dr. Patricia Ann Blackwell, MD Preventive Medicine - Occupational Medicine Medicare: Not Enrolled in Medicare Practice Location: 1905 Beaver Ruin Rd, Norcross, GA 30071 Phone: 770-441-0444 |
News Archive
QuadraMed® Corporation, a leading provider of healthcare information technologies and services that help turn quality care into positive financial outcomes, today announced that Wake Forest University Baptist Medical Center has selected QuadraMed's Enterprise Scheduling™ (QES) solution to schedule hospital ancillary procedures and accelerate reimbursements.
Achievement in the field of cancer research: Biologists and chemists at the University of Konstanz decipher a molecular mechanism of the cell with relevance for the development of cancer and the fight against that disease.
AcelRx Pharmaceuticals, Inc. announced today that results of its Phase 1 studies evaluating the pharmacokinetics of its oral transmucosal NanoTab(TM) formulation of sufentanil will be featured in two oral presentations at the upcoming American Society of Anesthesiologists Annual Meeting in New Orleans.
A diet rich in soy may help feminine hearts, but timing matters, finds a new study published online today in Menopause, the journal of The North American Menopause Society.
Today at the 95th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA), Bayer HealthCare Pharmaceuticals Inc. announced the enrollment of the first patient in an international Phase III clinical trial to evaluate the efficacy and safety of florbetaben (BAY 94-9172) PET imaging in the detection of beta-Amyloid plaques in the brain, which are a pathological hallmark of Alzheimer's disease.
› Verified 7 days ago